Lipid profile in people starting antiretroviral therapy with efavirenz or dolutegravir based regimens from a reference center in Brazil: a cohort study. RSD [Internet]. 2022 Apr. 15 [cited 2025 Dec. 6];11(5):e55811528662. Available from: https://rsdjournal.org/rsd/article/view/28662